✨ Your Portfolio is fetched and updated from zerodha.

Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (241 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
40.68
4,25,102
68.53
1,70,299
59.23
1,26,753
22.37
1,21,735
17.87
1,03,155
21.59
93,364
18.97
93,328
52.88
92,592
20.49
70,132
28.86
68,134
42.63
64,332
52.58
53,095
77.34
52,897
108
52,563
44.12
42,146
42.88
35,662
78.90
35,606
32.19
31,344
37.19
29,397
38.59
27,721
34.01
26,974
-
24,584
27.25
22,874
113
22,545
54.16
22,511
90.11
21,640
86.52
21,443
-
20,658
53.47
19,354
64.33
18,426
461
18,419
28.04
17,789
36.24
17,313
139
15,989
9.71
14,937
45.42
14,715
65.17
14,595
24.58
14,475
25.90
13,281
27.75
12,372
50.63
11,033
20.47
10,859
80.23
10,780
24.41
10,091
27.80
9,795
31.52
9,670
48.41
9,443
24.32
8,553
20.54
8,158
49.96
6,856
30.09
6,784
21.01
6,662
25.93
6,217
33.44
6,099
134
5,617
-
4,845
92.82
4,483
81.73
4,271
33.17
4,129
19.65
3,913
-
3,907
27.65
3,771
17.31
3,729
63.12
3,593
40.51
3,529
23.73
3,497
37.63
3,328
274
2,772
22.93
2,657
30.42
2,566
393
2,525
7.75
2,512
23.86
2,353
-
2,350
-
2,107
34.81
1,973
16.61
1,821
146
1,749
24.72
1,664
38.95
1,652
23.67
1,568
60.08
1,562
23.29
1,468
31.97
1,402
26.43
1,353
21.28
1,318
65.54
1,314
12.99
1,039
-
943
18.98
931
12.84
903
41.28
847
42.75
844
42.15
822
39.68
821
18.92
813
7.21
808
19.97
773
3.21
768
-
753
22.18
733
35.60
627
22.35
616
37.26
594
28.95
591
52.76
565
27.54
540
15.73
519
35.79
478
-30.04
453
41.17
432
22.23
416
36.61
415
62.47
413
-
410
43.47
381
74.99
380
30.80
362
53.35
351
42.97
346
-
341
19.61
334
144
297
25.54
295
95.76
294
29.80
292
29.59
284
71.66
257
62.04
255
37.80
251
9.97
242
49.99
227
30.19
225
23.26
224
22.93
223
-12.96
222
-
183
14.60
179
10.07
175
-
174
660
171
36.41
166
8.66
162
35.19
159
29.47
158
142
151
15.75
151
-5.34
147
31.09
145
13.03
144
10.38
141
16.87
135
12.91
124
17.51
120
16.51
118
-301
116
36.02
112
17.59
107
13.64
105
179
104
20.40
100
25.68
94
19.14
92
30.44
91
12.76
91
39.09
91
12.93
88
23.27
87
-5.20
86
7.99
86
-790
82
52.18
82
-
75
16.95
73
59.02
70
13.72
68
16.02
67
16.40
67
9.18
66
31.87
62
21.48
61
3.90
59
-
58
15.73
58
89.19
57
-7.91
53
252
51
-1.32
48
97.88
42
95.31
42
12.19
41
-19.47
41
27.85
40
9.43
39
-2.35
39
11.07
39
19.64
38
47.35
37
23.70
37
16.00
37
14.08
35
-33.99
35
73.57
34
-
32
7.94
32
9.23
31
138
31
34.04
29
38.64
29
161
29
-
28
11.18
23
33.65
22
62.03
21
21.63
21
71.70
21
-333
20
16.33
17
66.65
16
-1.29
16
-10.61
16
-24.42
15
-
15
-2.47
12
49.74
12
11.08
11
-20.77
10
21.81
10
-10.29
10
-
10
-1.34
7
87.37
7
317
7
-99.14
6
709
6
79.18
5
-9.97
5
-
5
29.31
4
-3.76
3
-5.85
2
Showing 5 241 of 241 Show More
Market Share

    Select a Metric
    • Fermentation Based API Products - Market Share (%)
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Vaccines - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Benzimidazole (%)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material